Dataset from Functional Impact of GLP-1 for Heart Failure Treatment
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00008635
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective is to test the hypothesis that, compared with placebo, therapy with
Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure Syndrome (AHFS) discharge
period will be associated with greater clinical stability at six months as assessed by a
composite clinical endpoint.
创建时间：
2026-02-05
